New thrombin inhibitors in cardiovascular disease
- 1 August 1997
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 1 (2) , 242-253
- https://doi.org/10.1016/s1367-5931(97)80016-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Current and future perspectives on antithrombotic therapy of acute myocardial infarctionEuropean Heart Journal, 1995
- Thrombin inhibitors A new generation of antithromboticsTrends in Cardiovascular Medicine, 1995
- Kinetic and Crystallographic Studies of Thrombin with Ac-(D)Phe-Pro-boroArg-OH and Its Lysine, Amidine, Homolysine, and Ornithine AnalogsBiochemistry, 1995
- Thrombin SpecificityThrombosis and Haemostasis, 1995
- Inhibition of clot-bound and free (fluid-phase thrombin) by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasmaBlood Coagulation & Fibrinolysis, 1994
- New Anticoagulant StrategiesDrugs, 1994
- Thrombin receptor function and cardiovascular diseaseTrends in Cardiovascular Medicine, 1994
- Late-fibrin(ogen) fragment E modulates human alpha-thrombin specificityEuropean Journal of Biochemistry, 1993
- Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisJournal of the American College of Cardiology, 1993
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991